|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00559689 |
|
Date of registration:
|
15/11/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
|
|
Scientific title:
|
Phase 4 Study of Once-Daily Inhaled Glucocorticosteroid Administration in Asthma Patients |
|
Date of first enrolment:
|
November 2005 |
|
Target sample size:
|
24 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00559689 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Crossover, Time Perspective: Cross-Sectional
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Kingo Chida, MD,PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Receive ICS for one year or more, with no change in dose within the previous 8 weeks
Exclusion Criteria:
- Two or more courses of oral corticosteroid in the previous 12 months
- Admission to hospital due to asthma in the previous 6 months
- Admission to the intensive care unit due to asthma at any time in the past
- Current cigarette smoker.
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Asthma
|
|
Intervention(s)
|
|
Drug: Budesonide,hydrofluoroalkane-beclomethasone
|
|
Drug: Budesonide,hydrofluoroalkane-beclomethasone dipropionate
|
|
Primary Outcome(s)
|
|
once-daily administration of inhaled glucocorticosteroids can control airway inflammation
[Time Frame: two-year]
|
|
Secondary ID(s)
|
|
H-17-43
|
|
Hamamatsu-17-43
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|